Tuesday, October 4, 2022


Biotechnology News Magazine

Holographyx Announces Holo-Blister® Granted a U.S. Patent

Holo-Blister® is a new anti-counterfeiting system for pharmaceutical blister-packs that has just been awarded patents in both the U.S. and Europe

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Holographyx Inc. announced that it has recently been granted a U.S. patent for its Holo-Blister® product along with a European Patent for the development of this unique and cost-effective method to apply holograms to the back of blister packs using conventional heat-seal blister packaging equipment.

Holo-Blister® holograms have been designed so that they will only be visible behind each pill/capsule cavity on the back of each blister pack, thereby allowing the printing of dosage and marketing information on the area surrounding the pill/capsule recess.

The size of the worldwide market for counterfeit pharmaceuticals has been estimated to be as much as $200 billion annually. Although anti-counterfeiting measures such as “track and trace” can be used to distinguish legitimate pharmaceutical products from counterfeits, these systems require consumers to go on-line to validate each of their pharmaceutical purchases.

Blister-packaging utilizing Holo-Blister® provides consumers with the ability to visually validate the authenticity of their purchases instantly with the use of custom holograms that, prior to the development of Holo-Blister®, would be extremely difficult to manufacture and apply.

Holographyx Inc. has been working with the Hazen Paper Company in cooperation with Uhlmann Packaging on the development, testing, and introduction of Holo-Blister®.

Holographyx Inc was founded in 1993 and developed and marketed the world’s first holographic scratch-off lottery ticket in conjunction with the Hazen Paper Company. Our Holographic scratch-off lottery tickets are now being used on an ongoing basis by a multitude of lotteries including 43 lotteries in the US as well as by more than a dozen additional lotteries worldwide. Holographyx has developed its Holo-Blister® product for the pharmaceutical industry and has been awarded U.S Patent # 11,052,020 B2 & European Patent # EP 3532005 with the additional US and worldwide patents pending. Holo-Blister ® is a registered trademark of Holographyx Inc.

Hazen Paper was founded in 1925 and is a leading paper converter specializing in holographic origination, film coating, foil and paper lamination, metallizing, gravure printing, specialty coating and rotary embossing to create specialty materials for worldwide use in retail display and POP, luxury, beauty, entertainment and media packaging, bookbinding, scratch-off lottery and other security-related tickets, tags, and cards. Hazen is committed to sustainability, using hydropower produced by the Connecticut River, with certification to supply converted paper and paperboards that are FSC, SFI and PEFC certified.

Uhlmann Pac-Systeme GmbH & Co. KG is a global leader in providing systems for packing pharmaceuticals in blister packaging, bottles, and cartons. In addition to its innovative packaging lines, Uhlmann offers consultation, project management, extensive services, and digital solutions from a single source. The company is part of the Uhlmann Group, which achieved a turnover of €423 million in the 2020/21 business year with around 2600 employees. Other companies in the Uhlmann Group are KOCH Pac-Systeme, Cremer Speciaalmachines, Wonder Packing Machinery and Axito.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine